Hepatitis delta virus and hepatocellular carcinoma: an update

Raffaella Romeo, Arnolfo Petruzziello, Eve Isabel Pecheur, Floriana Facchetti, Riccardo Perbellini, Enrico Galmozzi, Najeeb Ullah Khan, Lucia Di Capua, Rocco Sabatino, Gerardo Botti, Giovanna Loquercio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hepatitis delta virus (HDV) is a defective RNA virus that depends on the presence of hepatitis B virus (HBV) for the creation of new virions and propagation of the infection to hepatocytes. Chronic infection with HDV is usually associated with a worsening of HBV infection, leading more frequently to cirrhosis, increased risk of liver decompensation and hepatocellular carcinoma (HCC) occurrence. In spite of a progressive declining prevalence of both acute and chronic HDV infection observed over several years, mainly due to increased global health policies and mass vaccination against HBV, several European countries have more recently observed stable HDV prevalence mainly due to migrants from non-European countries. Persistent HDV replication has been widely demonstrated as associated with cirrhosis development and, as a consequence, development of liver decompensation and occurrence of HCC. Several treatment options have been attempted with poor results in terms of HDV eradication and improvement of long-term prognosis. A global effort is deemed urgent to enhance the models already existing as well as to learn more about HDV infection and correlated tumourigenesis mechanisms.

Original languageEnglish
Pages (from-to)1612-1618
Number of pages7
JournalEpidemiology and Infection
Volume146
Issue number13
DOIs
Publication statusPublished - 2018

Fingerprint

Hepatitis Delta Virus
Hepatocellular Carcinoma
Virus Diseases
Hepatitis B virus
Hepatitis D
Fibrosis
Mass Vaccination
Defective Viruses
Liver
RNA Viruses
Chronic Hepatitis
Virus Replication
Health Policy
Infection
Virion
Hepatocytes

Keywords

  • Cirrhosis
  • epidemiology
  • hepatitis delta virus
  • hepatocellular carcinoma
  • natural history
  • treatment

ASJC Scopus subject areas

  • Epidemiology
  • Infectious Diseases

Cite this

Hepatitis delta virus and hepatocellular carcinoma : an update. / Romeo, Raffaella; Petruzziello, Arnolfo; Pecheur, Eve Isabel; Facchetti, Floriana; Perbellini, Riccardo; Galmozzi, Enrico; Khan, Najeeb Ullah; Di Capua, Lucia; Sabatino, Rocco; Botti, Gerardo; Loquercio, Giovanna.

In: Epidemiology and Infection, Vol. 146, No. 13, 2018, p. 1612-1618.

Research output: Contribution to journalArticle

Romeo, R, Petruzziello, A, Pecheur, EI, Facchetti, F, Perbellini, R, Galmozzi, E, Khan, NU, Di Capua, L, Sabatino, R, Botti, G & Loquercio, G 2018, 'Hepatitis delta virus and hepatocellular carcinoma: an update', Epidemiology and Infection, vol. 146, no. 13, pp. 1612-1618. https://doi.org/10.1017/S0950268818001942
Romeo, Raffaella ; Petruzziello, Arnolfo ; Pecheur, Eve Isabel ; Facchetti, Floriana ; Perbellini, Riccardo ; Galmozzi, Enrico ; Khan, Najeeb Ullah ; Di Capua, Lucia ; Sabatino, Rocco ; Botti, Gerardo ; Loquercio, Giovanna. / Hepatitis delta virus and hepatocellular carcinoma : an update. In: Epidemiology and Infection. 2018 ; Vol. 146, No. 13. pp. 1612-1618.
@article{58c2ed49199b430e944323b35bc8edb3,
title = "Hepatitis delta virus and hepatocellular carcinoma: an update",
abstract = "Hepatitis delta virus (HDV) is a defective RNA virus that depends on the presence of hepatitis B virus (HBV) for the creation of new virions and propagation of the infection to hepatocytes. Chronic infection with HDV is usually associated with a worsening of HBV infection, leading more frequently to cirrhosis, increased risk of liver decompensation and hepatocellular carcinoma (HCC) occurrence. In spite of a progressive declining prevalence of both acute and chronic HDV infection observed over several years, mainly due to increased global health policies and mass vaccination against HBV, several European countries have more recently observed stable HDV prevalence mainly due to migrants from non-European countries. Persistent HDV replication has been widely demonstrated as associated with cirrhosis development and, as a consequence, development of liver decompensation and occurrence of HCC. Several treatment options have been attempted with poor results in terms of HDV eradication and improvement of long-term prognosis. A global effort is deemed urgent to enhance the models already existing as well as to learn more about HDV infection and correlated tumourigenesis mechanisms.",
keywords = "Cirrhosis, epidemiology, hepatitis delta virus, hepatocellular carcinoma, natural history, treatment",
author = "Raffaella Romeo and Arnolfo Petruzziello and Pecheur, {Eve Isabel} and Floriana Facchetti and Riccardo Perbellini and Enrico Galmozzi and Khan, {Najeeb Ullah} and {Di Capua}, Lucia and Rocco Sabatino and Gerardo Botti and Giovanna Loquercio",
year = "2018",
doi = "10.1017/S0950268818001942",
language = "English",
volume = "146",
pages = "1612--1618",
journal = "Epidemiology and Infection",
issn = "0950-2688",
publisher = "Cambridge University Press",
number = "13",

}

TY - JOUR

T1 - Hepatitis delta virus and hepatocellular carcinoma

T2 - an update

AU - Romeo, Raffaella

AU - Petruzziello, Arnolfo

AU - Pecheur, Eve Isabel

AU - Facchetti, Floriana

AU - Perbellini, Riccardo

AU - Galmozzi, Enrico

AU - Khan, Najeeb Ullah

AU - Di Capua, Lucia

AU - Sabatino, Rocco

AU - Botti, Gerardo

AU - Loquercio, Giovanna

PY - 2018

Y1 - 2018

N2 - Hepatitis delta virus (HDV) is a defective RNA virus that depends on the presence of hepatitis B virus (HBV) for the creation of new virions and propagation of the infection to hepatocytes. Chronic infection with HDV is usually associated with a worsening of HBV infection, leading more frequently to cirrhosis, increased risk of liver decompensation and hepatocellular carcinoma (HCC) occurrence. In spite of a progressive declining prevalence of both acute and chronic HDV infection observed over several years, mainly due to increased global health policies and mass vaccination against HBV, several European countries have more recently observed stable HDV prevalence mainly due to migrants from non-European countries. Persistent HDV replication has been widely demonstrated as associated with cirrhosis development and, as a consequence, development of liver decompensation and occurrence of HCC. Several treatment options have been attempted with poor results in terms of HDV eradication and improvement of long-term prognosis. A global effort is deemed urgent to enhance the models already existing as well as to learn more about HDV infection and correlated tumourigenesis mechanisms.

AB - Hepatitis delta virus (HDV) is a defective RNA virus that depends on the presence of hepatitis B virus (HBV) for the creation of new virions and propagation of the infection to hepatocytes. Chronic infection with HDV is usually associated with a worsening of HBV infection, leading more frequently to cirrhosis, increased risk of liver decompensation and hepatocellular carcinoma (HCC) occurrence. In spite of a progressive declining prevalence of both acute and chronic HDV infection observed over several years, mainly due to increased global health policies and mass vaccination against HBV, several European countries have more recently observed stable HDV prevalence mainly due to migrants from non-European countries. Persistent HDV replication has been widely demonstrated as associated with cirrhosis development and, as a consequence, development of liver decompensation and occurrence of HCC. Several treatment options have been attempted with poor results in terms of HDV eradication and improvement of long-term prognosis. A global effort is deemed urgent to enhance the models already existing as well as to learn more about HDV infection and correlated tumourigenesis mechanisms.

KW - Cirrhosis

KW - epidemiology

KW - hepatitis delta virus

KW - hepatocellular carcinoma

KW - natural history

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85049922856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049922856&partnerID=8YFLogxK

U2 - 10.1017/S0950268818001942

DO - 10.1017/S0950268818001942

M3 - Article

AN - SCOPUS:85049922856

VL - 146

SP - 1612

EP - 1618

JO - Epidemiology and Infection

JF - Epidemiology and Infection

SN - 0950-2688

IS - 13

ER -